Cramer: Illogical Issues Winning Over Fundamentals

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Is this a change from Cramer on his stance on Big Pharma?  He is saying Pharma isn’t working this morning in TheStreet.com video today.

He said options are driving trading instead of fundamentals, and that is why Goldman (GS) is hugging $200.00; and he noted Texas Instruments (TXN) going up is a little illogical based on how bad the news was last night.

He thinks the drillers are winning from legislation and developments (Washington Post article) regardless of oil prices next year: he likes (CLB) Core Labs NV and (HAL) Halliburton, although he has been riding these ponies for some time.

PHARMA is not working, even biotech in general, except for Celgene (CELG) and Genentech (DNA) as two names he was ok on.   He thinks the day is a wash and this is not a fundamental day, otherwise Texas Instruments would be down. 

My take on TXN is the same as his and other "non-bulge bracket firms" that evaluated the news.  It might not be fair to say that the street is conflicted in TXN, but the warning was worse than the worse whisper and the guidance for Q1 being even lower signals the real industry trends.  We still also have several big chip giants that haven’t yet come clean with any guidance, and that is still a potential headline risk.  It is truly illogical about the TXN rise today, although so far it has been marginal.  There is another interesting article worth noting, and while I do not really agree with the real extreme timeframe I definitely agree with the basis and the probability that you will see lower prices in TXN from here.

Jon C. Ogg
December 12, 2006

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

AKAM Vol: 21,556,944
MU Vol: 65,135,624
INTC Vol: 227,504,426
MNST Vol: 15,284,847
DELL Vol: 12,167,525

Top Losing Stocks

MSI Vol: 3,101,643
EXPE Vol: 4,189,786
CTRA Vol: 73,319,495